🇺🇸 FDA
Patent

US 9624182

Compounds as lysophosphatidic acid receptor antagonists

granted A61KA61K31/42A61K31/422

Quick answer

US patent 9624182 (Compounds as lysophosphatidic acid receptor antagonists) held by AMIRA PHARMACEUTICALS, INC. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/42, A61K31/422, A61K31/427, A61K31/4439